Global Cord Blood Corporation (CORBF)
- Previous Close
1.2500 - Open
1.2000 - Bid --
- Ask --
- Day's Range
1.2000 - 1.2500 - 52 Week Range
1.2000 - 2.9900 - Volume
8,226 - Avg. Volume
3,530 - Market Cap (intraday)
167.394M - Beta (5Y Monthly) -0.25
- PE Ratio (TTM)
2.19 - EPS (TTM)
0.5700 - Earnings Date Apr 15, 2024 - Apr 16, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date Jul 31, 2018
- 1y Target Est
--
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.
www.globalcordbloodcorp.com1,202
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Related News
Performance Overview: CORBF
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CORBF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CORBF
Valuation Measures
Market Cap
167.39M
Enterprise Value
-752.54M
Trailing P/E
2.20
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.89
Price/Book (mrq)
0.25
Enterprise Value/Revenue
-0.61
Enterprise Value/EBITDA
-1.15
Financial Highlights
Profitability and Income Statement
Profit Margin
40.30%
Return on Assets (ttm)
4.63%
Return on Equity (ttm)
10.99%
Revenue (ttm)
1.24B
Net Income Avi to Common (ttm)
501.06M
Diluted EPS (ttm)
0.5700
Balance Sheet and Cash Flow
Total Cash (mrq)
6.66B
Total Debt/Equity (mrq)
0.00%
Levered Free Cash Flow (ttm)
378.58M